Glyoka-VM1 Tablet SR
Glyoka-VM1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹48
that's 61% off!
About This Medicine
Product description & overview
Glyoka-VM1 Tablet SR: A Comprehensive Approach to Diabetes Management
Glyoka-VM1 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose, specifically formulated to address Type 2 diabetes. Each tablet provides a precisely measured dose of these active ingredients for optimal efficacy.
Glimepiride (1mg): This sulfonylurea increases insulin secretion from the pancreas, helping lower blood sugar levels.
Metformin (500mg): A first-line choice for managing blood glucose, metformin helps the body utilize existing insulin more effectively and reduce glucose production in the liver.
Voglibose (0.2mg): This alpha-glucosidase inhibitor slows down the absorption of sugars from the digestive system after meals, further controlling postprandial hyperglycemia.
Glyoka-VM1 Tablet SR is designed to provide comprehensive management of Type 2 diabetes for individuals with varying needs and sensitivities. It's important to follow your healthcare provider's instructions when using this medication.
Please note: This description provides general information about Glyoka-VM1 Tablet SR. Consult a medical professional for personalized advice and dosage recommendations. Always consult before making any changes to your healthcare regimen.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glyoka-VM1 Tablet SR.
High Risk
Pregnancy
Glyoka-VM1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glyoka-VM1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glyoka-VM1 Tablet SR may be needed. Please consult your doctor. Glyoka-VM1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glyoka-VM1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glyoka-VM1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glyoka-VM1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glyoka-VM1 Tablet SR
Products matching your search
Insugen 30/70 100IU Refil Cartridge
Insugen 30/70 100IU Refil Cartridge
Zymride M 3 Forte Tablet PR
Zymride M 3 Forte Tablet PR
Jodapa 5mg Tablet
Jodapa 5mg Tablet
Zoryl M 3 Forte Tablet PR
Zoryl M 3 Forte Tablet PR
Esipram 10 Tablet
Esipram 10 Tablet
Linero D 10mg/5mg Tablet
Linero D 10mg/5mg Tablet
Xenia 10 Tablet
Xenia 10 Tablet
K-Glim-M Forte 2mg Tablet